Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Microneedle Drug Delivery Systems Market Outlook (2023 to 2033)

As per the latest market research conducted by FMI, the global microneedle drug delivery systems market is expected to record a CAGR of 6.6% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of US$ 768.9 million. By 2033, the valuation is anticipated to reach US$ 1459.1 million.

In order to administer enough doses of medication to have the desired therapeutic effect, hundreds of microneedles are arranged in arrays on a small patch. As a result, there is now a direct route for a medication to enter the viable epidermis without coming into contact with the nerves and blood vessels found in the dermal layers. Depending on their qualities, numerous types of materials, including ceramic, silicon, silica glass, carbohydrates, and polymers, are utilized to make microneedles, thus driving the microneedling tool market in the coming years. Typically, microneedles measure hundreds of microns in length, 1 to 50 micrometers in width at the tip, and 50 to 300 micrometers in length at the base.

Significant Market Trends:

  • The significant element promoting the growth of the market is the increased focus on improving the state of healthcare facilities, microneedling treatment, and the infrastructure for healthcare as a whole. Which on the other hand is expected to drive the growth of the microneedling treatment market.
  • Increased public-private partnerships and strategic partnerships for the purpose of funding and implementing new and improved technology are also opening up lucrative market prospects for the plasma microneedling market as well.
  • One of the key factors driving the market's growth is the rising global population of overweight and obese people.
  • The countries with the greatest obesity rates are India, Germany, China, the United States, and the United Kingdom. Many health issues in the body are caused by obesity. Diabetes, respiratory issues, and other acute and chronic illnesses are a few examples.
  • Likewise, an increase in public-private funding for targeted research initiatives, growing awareness of the harmful effects of obesity on the body, an increase in the prevalence of chronic and acute illnesses, a rise in the global geriatric population, and an increase in product innovations and development as a result of technological advancements which is expected to create lucrative opportunities for market participants during the forecast period.
  • Increasing investment in research & development, particularly in developed and developing nations, is likely to open up lucrative market expansion opportunities for medical instruments and technologies. The market growth rate is also being boosted by research and development efforts to produce the finest possible treatments to combat obesity.
  • In the future, the market's growth rate is likely to be increased by the availability of safer alternatives to traditional hypodermic injection, increasing demand for less invasive drug delivery systems, growing internet penetration rate, increase in cardiovascular disease cases, and rising per capita spending on health care.
Attributes Value
Microneedle Drug Delivery Systems Value (2022) US$ 722.2 million
Microneedle Drug Delivery Systems Market Expected Value (2023) US$ 768.9 million
Microneedle Drug Delivery Systems Market Forecast Value (2033) US$ 1459.1 million
Microneedle Drug Delivery Systems Market Expected CAGR (2023 to 2033) 6.6%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Restraining Factors of the Microneedle Drug Delivery Systems Market

  • Nevertheless, constraints to market expansion are anticipated to include high costs associated with research and development capabilities, a lack of adequate infrastructure, unequal access to medical services, growing interest in alternative drug delivery methods like transdermal and intradermal systems, and a lack of awareness in developing nations.
  • Besides, it is anticipated that the absence of a favorable reimbursement scenario, a lack of technology penetration in developing economies, poor absorption and variation in absorption, a lack of adequate infrastructure in low- and middle-income groups, limited insurance coverage, and a lack of regulatory compliance is anticipated to pose challenges to the market during the forecast period.

Comparative Analysis of Adjacent Markets

Microneedle Drug Delivery Systems Market:

Differentiating Aspects Microneedle Drug Delivery Systems Market
Anticipated CAGR (2023 to 2033) 6.6%
Market Valuation (2023) US$ 768.9 million
Growth Factors The rising population of obese people.
Future Opportunities The increased focus on improving the state of healthcare facilities and the infrastructure for healthcare as a whole.
Market Trends Increased public-private partnerships and strategic partnerships.

Respiratory Pathogen Testing Kits Market:

Differentiating Aspects Respiratory Pathogen Testing Kits Market
Anticipated CAGR (2023 to 2033) 5.7%
Market Valuation (2023) US$ 4083.1 million
Growth Factors Rising chronic illness prevalence and increasing pathogen testing and preventative healthcare awareness.
Future Opportunities The market for respiratory pathogen testing kits is driven by a significant increase in respiratory illness incidences.
Market Trends Future market demand is likely to be profitable since developing and emerging economies have access to improved healthcare facilities.

Blood Transfusion Market:

Differentiating Aspects Blood Transfusion Market
Anticipated CAGR (2023 to 2033) 7%
Market Valuation (2023) US$ 4.69 billion
Growth Factors Blood transfusion demand is predicted to rise due to an increase in anemic people who require red blood cell transfusions to treat their condition.
Future Opportunities The use of stem cell technologies to manufacture lab-grown blood cells for human transfusion is one of the most advanced research procedures and is expected to create multiple opportunities.
Market Trends The emergence of cost-effective and novel technology to inactivate or minimize the risk of infection is increasing demand for a pathogen reduction system.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Primary Market Trends

  • The emergence of safer substitutes for traditional hypodermic injections is the main factor behind the expansion of microneedle drug delivery systems.
  • The popularity of safety concerns is another primary trend boosting the development of microneedle drug delivery systems.
  • The launch of a new microneedle patch is expected to make it simpler to vaccinate people in the event of preventable diseases as percenters for disease control and prevention.
  • Consequently, the need for microneedle drug delivery systems is increasing as a result of vaccines against numerous diseases like measles.
  • Besides this, the microneedle patch can be given by medical professionals with little training.
  • The most significant factor driving the market for microneedle drug delivery systems is the high adoption of emerging safety issues that have short- and long-term implications for clinicians, patients, health workers, and regulators, growing research and development measures, and increasing demands for a safer alternative to traditional hypodermic injections.

Developments in the Market

  • According to the WHO, new instances of cancer are anticipated to increase by roughly 70% over the following 20 years, which may lead to a need for microneedle patches as a drug delivery method. The market for microneedle drug delivery systems is expected to be driven by advances in technology like microneedle patches and an increase in transdermal drug delivery applications for pain treatment, congestive heart failure, and hormone replacement. The market expansion for microneedle drug delivery systems is anticipated to be hampered by drug degradation, local discomfort, poor absorption, and variability in absorption.
  • The Centers for Disease Control and Prevention claim that a new microneedle patch might make it simpler to immunize people against measles and other diseases that can be prevented by vaccination. Due to the highly contagious nature of the measles virus, measures should be taken throughout the production and administration of the vaccine. Every year, measles affects over 25 million people, and sadly, the global measles vaccination rate has been hovering around 85% for the past few years, which is below the target level.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

How The Market Progressed Till June 2022?

Particulars Details
H1, 2021 6.46%
H1, 2022 Projected 6.60%
H1, 2022 Outlook 6.10%
BPS Change - H1, 2022 (O) - H1, 2022 (P) (-) 50 ↓
BPS Change - H1, 2022 (O) - H1, 2021 (-) 36 ↓

The comparative analysis and market growth rate of the global microneedle drug delivery systems market as studied by Future Market Insights shows a negative BPS growth in the H1-2022 outlook as compared to H1-2022 projected period by 50 BPS, and, a decline in the BPS growth is expected in H1-2022 over H1- 2021 duration with 36 basis point share (BPS).

The expensive costs of creating a reproducible microneedle patch as well as the high expenses of storing and packaging microneedles for safe distribution are also factors that have been cited as limiting the decline in BPS levels.

The market is expected to gain momentum towards expansion over the anticipated years thanks to the advantages of microneedles in advanced transdermal drug administration, including enhanced bioavailability of pharmaceuticals, reduced side effects, and rapid beginning of therapeutic action. The introduction of solid, dissolving, and coated microneedles for efficient transdermal drug administration is one of the market's major advances. With regard to medication safety and product licensing operations, the market for microneedle drug delivery systems is subject to changes based on regulatory and industry dynamics.

Country-wise Analysis

How is the United States Market for Microneedle Drug Delivery Systems Performing?

The Demand for Microneedles for Drug Delivery is Being Driven by an Increase in Cancer Patients

The demand for innovative and efficient drug delivery methods to enhance therapy is being driven by the rising prevalence of chronic diseases in the United States, including diabetes and cancer. As a result, businesses and research organizations are bringing new product development to the nation, establishing it as a profitable segment.

In 2022, the United States witnessed 1.9 million new cancer cases diagnosed and 609,360 cancer deaths, according to Cancer Facts & Figures (2022), an educational companion to Cancer Statistics (2022), an article published in the American Cancer Society journal. This is expected to encourage the development of new oncology treatments, driving the market for microneedle drug delivery systems in the country.

Why is the Demand for Microneedle Drug Delivery Systems in China Increasing so Rapidly?

Demand for High-Quality Drugs & Access to Low-Cost Raw Ingredients Allows China to Expand its Industry

China is anticipated to hold a significant position in the East Asia market over the projection period. China's government organizations are investing more money in developing the healthcare industry, which is fostering the production of novel pharmaceuticals therein.

Several international pharmaceutical companies are looking to expand their operations in China due to the abundance of low-cost raw materials and the increased demand for generic medicines.

Growth Outlook of Country-wise Insights:

Country United States
CAGR (2018 to 2022) 5.1%
CAGR (2023 to 2033) 5.7%
Valuation (2033) US$ 528.6 million
Country United Kingdom
CAGR (2018 to 2022) 6.4%
CAGR (2023 to 2033) 7.0%
Valuation (2033) US$ 84.4 million
Country China
CAGR (2018 to 2022) 5.7%
CAGR (2023 to 2033) 6.2%
Valuation (2033) US$ 77.1 million
Country Germany
CAGR (2018 to 2022) 4.7%
CAGR (2023 to 2033) 5.1%
Valuation (2033) US$ 79.3 million

Category-wise Analysis

Which Product Type Is Expected to Become Very Popular?

Solid Microneedles Dominate the Development of Microneedle Drug Delivery Devices

Solid microneedles remain the market leader despite a slight decline in market share during the anticipated time frame. They are anticipated to have covered more than 50% of the market by the end of 2033. In the meantime, hollow and dissolving microneedles are anticipated to proliferate more quickly with the usage of new technologies and uses.

Research on solid microneedles is now being conducted for several applications in an effort to increase their consistency, stability, and affordability. At the moment, research is concentrated on the creation of a microneedle array.

Which End User Segment is Predicted to Flourish in the Microneedle Drug Delivery Systems Market?

Hospitals Set to Account for Higher Consumption of Microneedles for Drug Delivery

In 2022, hospitals held a top position as end users, accounting for 44.1% of the global market. The expansion of the worldwide microneedle drug delivery systems market is anticipated to be aided by specialty clinics.

Specialty clinics held a 22% market share globally in 2022. As more clinics focus on particular disorders, the market potential is anticipated to rise in the future. For instance, one of the biggest consumers of microneedle drug delivery devices for procedures like hair restoration, facelifts, and wrinkle therapy are cosmetic clinics. Which is expected to eventually drive the microneedling for hair loss market.

Competitive Background

The global microneedle drug delivery systems market is dominated by large- and medium-sized companies. However, it is led by a few important companies that, as part of their marketing strategy, are focusing on their market and value chain positions. Prominent market players use a range of tactics, such as early market entry, deep market penetration, as well as exclusive marketing and distribution licensing. Product innovation and differentiation, however, are essential market strategies for both mid-size and large businesses due to the diversity of market players.

Regardless of their size, companies use distribution rights acquisition and exclusive technology licensing as core strategies. In particular, a few businesses are focusing on strategic alliances in order to get a competitive edge.

Leading companies that sell microneedle drug delivery equipment are concentrating on Research and Development to introduce cutting-edge items in the market. In order to obtain a competitive edge in the market, firms are also engaging in mergers, acquisitions, and collaborations.

Significant Market Players Include

  • 3M Company
  • Becton
  • Dickinson and Company
  • Zosano Pharma Corporation
  • Raphas Co. Ltd.
  • Nanopass Tech
  • Corium International Inc.
  • Valeritas Inc.
  • Nitto Denko Corporation
  • Microdermics Inc.
  • TheraJect Inc.
  • Vaxxas Pty Ltd.
  • Endoderma Ltd.
  • QuadMedicine
  • SNvia Co. Ltd.
  • Small Lab
  • AdminMed nanoBioSciences LLC

Microneedle Drug Delivery Systems Industry Report Scope

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Market Analysis US$ million for Value
Key Regions Covered
  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa (MEA)
Key Countries Covered
  • United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • Türkiye
  • South Africa
  • GCC Countries
Key Market Segments Covered
  • Product
  • End User
  • Region
Key Companies Profiled
  • 3M Company
  • Becton
  • Dickinson and Company
  • Zosano Pharma Corporation
  • Raphas Co. Ltd.
  • Nanopass Tech
  • Corium International Inc.
  • Valeritas Inc.
  • Nitto Denko Corporation
  • Microdermics Inc.
  • TheraJect Inc.
  • Vaxxas Pty Ltd.
  • Endoderma Ltd.
  • QuadMedicine
  • SNvia Co. Ltd.
  • Small Lab
  • AdminMed nanoBioSciences LLC
Pricing Available upon Request

Key Segments of Microneedle Drug Delivery Systems Industry Survey

Microneedle Drug Delivery Systems Market by Product:

  • Solid Microneedles
    • Silicon
    • Metal
    • Polymer
  • Hollow Microneedles
  • Dissolving Microneedles

Microneedle Drug Delivery Systems Market by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Academic Institutions
  • Research Institutes

Microneedle Drug Delivery Systems Market by Region:

  • North America Microneedle Drug Delivery Systems Market
  • Latin America Microneedle Drug Delivery Systems Market
  • Europe Microneedle Drug Delivery Systems Market
  • East Asia Microneedle Drug Delivery Systems Market
  • South Asia & Pacific Microneedle Drug Delivery Systems Market
  • Middle East & Africa (MEA) Microneedle Drug Delivery Systems Market

Frequently Asked Questions

What is the Revenue Generating Capacity of the Global Microneedle Drug Delivery Systems Market?

The market may register a revenue of US$ 768.9 million in 2023.

Which Country is Leading in the Microneedle Drug Delivery Systems Market?

The United States is the leading country in the market.

Which Asian Country is Dominating the Market?

China is the leading market and is expected to grow at 6.2% until 2033.

Based on Product Type, Which Segment Dominates the Market?

The solid microneedle segment dominates and could hold 50% of the global market by 2033.

Which is the Leading End-user Type in the Market?

The hospitals segment accounted the top position with 44.1% market share in 2022.

Table of Content

1. Executive Summary | Microneedle Drug Delivery Systems Market 

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033

        5.3.1. Solid Microneedles

            5.3.1.1. Silicon

            5.3.1.2. Metal

            5.3.1.3. Polymer

        5.3.2. Hollow Microneedles

        5.3.3. Dissolving Microneedles

    5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End Use

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By End Use, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End Use, 2023 to 2033

        6.3.1. Hospitals

        6.3.2. Ambulatory Surgical Centers

        6.3.3. Specialty Clinics

        6.3.4. Academic Institutions

        6.3.5. Research Institutes

    6.4. Y-o-Y Growth Trend Analysis By End Use, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By End Use, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. South Asia

        7.3.5. East Asia

        7.3.6. Oceania

        7.3.7. Middle East and Africa

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        8.2.1. By Country

            8.2.1.1. USA

            8.2.1.2. Canada

        8.2.2. By Product

        8.2.3. By End Use

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Product

        8.3.3. By End Use

    8.4. Key Takeaways

9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Product

        9.2.3. By End Use

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product

        9.3.3. By End Use

    9.4. Key Takeaways

10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. United Kingdom

            10.2.1.2. Spain

            10.2.1.3. Germany

            10.2.1.4. Italy

            10.2.1.5. France

            10.2.1.6. Rest of Europe

        10.2.2. By Product

        10.2.3. By End Use

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product

        10.3.3. By End Use

    10.4. Key Takeaways

11. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. India

            11.2.1.2. Malaysia

            11.2.1.3. Indonesia

            11.2.1.4. Thailand

            11.2.1.5. Rest of South Asia

        11.2.2. By Product

        11.2.3. By End Use

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product

        11.3.3. By End Use

    11.4. Key Takeaways

12. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

        12.2.2. By Product

        12.2.3. By End Use

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product

        12.3.3. By End Use

    12.4. Key Takeaways

13. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. Australia

            13.2.1.2. New Zealand

        13.2.2. By Product

        13.2.3. By End Use

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product

        13.3.3. By End Use

    13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. South Africa

            14.2.1.2. GCC Countries

            14.2.1.3. Rest of Middle East and Africa

        14.2.2. By Product

        14.2.3. By End Use

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product

        14.3.3. By End Use

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2022

            15.1.2.1. By Product

            15.1.2.2. By End Use

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2022

            15.2.2.1. By Product

            15.2.2.2. By End Use

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2022

            15.3.2.1. By Product

            15.3.2.2. By End Use

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2022

            15.4.2.1. By Product

            15.4.2.2. By End Use

    15.5. United Kingdom

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2022

            15.5.2.1. By Product

            15.5.2.2. By End Use

    15.6. Spain

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2022

            15.6.2.1. By Product

            15.6.2.2. By End Use

    15.7. Germany

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2022

            15.7.2.1. By Product

            15.7.2.2. By End Use

    15.8. Italy

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2022

            15.8.2.1. By Product

            15.8.2.2. By End Use

    15.9. France

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2022

            15.9.2.1. By Product

            15.9.2.2. By End Use

    15.10. India

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2022

            15.10.2.1. By Product

            15.10.2.2. By End Use

    15.11. Malaysia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2022

            15.11.2.1. By Product

            15.11.2.2. By End Use

    15.12. Indonesia

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2022

            15.12.2.1. By Product

            15.12.2.2. By End Use

    15.13. Thailand

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2022

            15.13.2.1. By Product

            15.13.2.2. By End Use

    15.14. China

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2022

            15.14.2.1. By Product

            15.14.2.2. By End Use

    15.15. Japan

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2022

            15.15.2.1. By Product

            15.15.2.2. By End Use

    15.16. South Korea

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2022

            15.16.2.1. By Product

            15.16.2.2. By End Use

    15.17. Australia

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2022

            15.17.2.1. By Product

            15.17.2.2. By End Use

    15.18. New Zealand

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2022

            15.18.2.1. By Product

            15.18.2.2. By End Use

    15.19. South Africa

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2022

            15.19.2.1. By Product

            15.19.2.2. By End Use

    15.20. GCC Countries

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2022

            15.20.2.1. By Product

            15.20.2.2. By End Use

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Product

        16.3.3. By End Use

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. 3M Company

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. Becton, Dickinson and Company

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. Zosano Pharma Corporation

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. RAPHAS Co., Ltd.

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. Nanopass Tech

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. Corium International, Inc.

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

        17.1.7. Valeritas, Inc.

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

        17.1.8. Nitto Denko Corporation

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

        17.1.9. Microdermics, Inc.

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

        17.1.10. TheraJect Inc.

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

        17.1.11. Vaxxas Pty Ltd.

            17.1.11.1. Overview

            17.1.11.2. Product Portfolio

            17.1.11.3. Profitability by Market Segments

            17.1.11.4. Sales Footprint

            17.1.11.5. Strategy Overview

                17.1.11.5.1. Marketing Strategy

        17.1.12. Endoderma Ltd.

            17.1.12.1. Overview

            17.1.12.2. Product Portfolio

            17.1.12.3. Profitability by Market Segments

            17.1.12.4. Sales Footprint

            17.1.12.5. Strategy Overview

                17.1.12.5.1. Marketing Strategy

        17.1.13. QuadMedicine

            17.1.13.1. Overview

            17.1.13.2. Product Portfolio

            17.1.13.3. Profitability by Market Segments

            17.1.13.4. Sales Footprint

            17.1.13.5. Strategy Overview

                17.1.13.5.1. Marketing Strategy

        17.1.14. SNvia Co., Ltd.

            17.1.14.1. Overview

            17.1.14.2. Product Portfolio

            17.1.14.3. Profitability by Market Segments

            17.1.14.4. Sales Footprint

            17.1.14.5. Strategy Overview

                17.1.14.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Recommendations

Healthcare

Chiari Malformation Treatment Market

Published : March 2023

Healthcare

Carcinoid Tumor Syndrome Management Market

Published : March 2023

Explore Healthcare Insights

View Reports

Microneedle Drug Delivery Systems Market